Citigroup’s Herbalife HLF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.94M | Sell |
200,000
-200,000
| -50% | -$3.27M | ﹤0.01% | 2394 |
|
|
2025
Q4 | $5.16M | Hold |
400,000
| – | – | ﹤0.01% | 1988 |
|
|
2025
Q3 | $3.38M | Sell |
400,000
-250,000
| -38% | -$2.36M | ﹤0.01% | 2272 |
|
|
2025
Q2 | $5.6M | Buy |
650,000
+550,000
| +550% | +$4.09M | ﹤0.01% | 1793 |
|
|
2025
Q1 | $863K | Buy |
+100,000
| New | +$711K | ﹤0.01% | 3351 |
|
|
2023
Q1 | – | Sell |
-74,100
| Closed | -$1.1M | – | 5645 |
|
|
2022
Q4 | $1.1M | Hold |
74,100
| – | – | ﹤0.01% | 2531 |
|
|
2022
Q3 | $1.47M | Sell |
74,100
-81,100
| -52% | -$2.01M | ﹤0.01% | 2398 |
|
|
2022
Q2 | $3.17M | Buy |
+155,200
| New | +$3.84M | ﹤0.01% | 1785 |
|
|
2021
Q1 | – | Sell |
-86,400
| Closed | -$4.15M | – | 6742 |
|
|
2020
Q4 | $4.15M | Sell |
86,400
-900
| -1% | -$43.4K | ﹤0.01% | 2219 |
|
|
2020
Q3 | $4.07M | Sell |
87,300
-76,300
| -47% | -$3.75M | ﹤0.01% | 2043 |
|
|
2020
Q2 | $7.36M | Sell |
163,600
-23,300
| -12% | -$905K | 0.01% | 1555 |
|
|
2020
Q1 | $5.45M | Sell |
186,900
-73,500
| -28% | -$2.74M | ﹤0.01% | 1591 |
|
|
2019
Q4 | $12.4M | Buy |
260,400
+100,600
| +63% | +$4.36M | 0.01% | 1300 |
|
|
2019
Q3 | $6.05M | Buy |
159,800
+43,400
| +37% | +$1.69M | ﹤0.01% | 1775 |
|
|
2019
Q2 | $4.98M | Buy |
116,400
+30,600
| +36% | +$1.45M | ﹤0.01% | 1979 |
|
|
2019
Q1 | $4.55M | Sell |
85,800
-806,400
| -90% | -$46.3M | ﹤0.01% | 1878 |
|
|
2018
Q4 | $52.6M | Buy |
892,200
+114,000
| +15% | +$6.29M | 0.05% | 387 |
|
|
2018
Q3 | $42.5M | Buy |
778,200
+25,700
| +3% | +$1.42M | 0.04% | 466 |
|
|
2018
Q2 | $40.4M | Sell |
752,500
-71,700
| -9% | -$3.77M | 0.04% | 443 |
|
|
2018
Q1 | $40.2M | Buy |
824,200
+336,200
| +69% | +$14.3M | 0.03% | 468 |
|
|
2017
Q4 | $16.5M | Sell |
488,000
-145,400
| -23% | -$5.09M | 0.01% | 960 |
|
|
2017
Q3 | $21.5M | Buy |
633,400
+76,200
| +14% | +$2.61M | 0.02% | 751 |
|
|
2017
Q2 | $19.9M | Buy |
557,200
+108,000
| +24% | +$3.64M | 0.02% | 753 |
|
|
2017
Q1 | $13.1M | Buy |
449,200
+163,600
| +57% | +$4.55M | 0.01% | 965 |
|
|
2016
Q4 | $6.87M | Sell |
285,600
-17,800
| -6% | -$486K | 0.01% | 1515 |
|
|
2016
Q3 | $9.4M | Buy |
303,400
+126,400
| +71% | +$3.99M | 0.01% | 1132 |
|
|
2016
Q2 | $5.18M | Buy |
177,000
+75,200
| +74% | +$2.25M | 0.01% | 1561 |
|
|
2016
Q1 | $3.13M | Sell |
101,800
-855,400
| -89% | -$22.1M | ﹤0.01% | 1997 |
|
|
2015
Q4 | $25.7M | Buy |
957,200
+85,200
| +10% | +$2.37M | 0.03% | 625 |
|
|
2015
Q3 | $23.8M | Sell |
872,000
-154,400
| -15% | -$4.23M | 0.02% | 638 |
|
|
2015
Q2 | $28.3M | Sell |
1,026,400
-244,400
| -19% | -$5.92M | 0.03% | 617 |
|
|
2015
Q1 | $27.2M | Sell |
1,270,800
-1,929,400
| -60% | -$32.9M | 0.03% | 613 |
|
|
2014
Q4 | $60.3M | Buy |
3,200,200
+805,600
| +34% | +$17.2M | 0.05% | 342 |
|
|
2014
Q3 | $52.4M | Buy |
2,394,600
+235,200
| +11% | +$6.28M | 0.05% | 370 |
|
|
2014
Q2 | $69.7M | Buy |
2,159,400
+447,800
| +26% | +$13.7M | 0.07% | 272 |
|
|
2014
Q1 | $49M | Sell |
1,711,600
-334,600
| -16% | -$11.1M | 0.05% | 331 |
|
|
2013
Q4 | $80.5M | Sell |
2,046,200
-22,600
| -1% | -$783K | 0.07% | 248 |
|
|
2013
Q3 | $72.2M | Sell |
2,068,800
-80,200
| -4% | -$2.48M | 0.07% | 256 |
|
|
2013
Q2 | $48.5M | Buy |
+2,149,000
| New | +$45.8M | 0.05% | 321 |
|
Other funds holding HLF
BG
ROIC
VPM
VCM
Citigroup's HLF Position: Q1 2026 in Review
Citigroup reduced its Herbalife (HLF) stake by 31% in Q1 2026, selling an estimated $8.37M and leaving 1,162,649 shares worth $17.1M. The position accounts for 0.01% of the portfolio, ranked #1159.
Citigroup first reported a position in HLF in Q2 2013 and has held it in 52 quarters since. The position peaked at $42M in Q2 2020. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.
- Citigroup held 1,162,649 shares of Herbalife worth $17.1M as of Q1 2026.
- Citigroup sold 512,480 Herbalife shares in Q1 2026, an estimated $8.37M.
- Herbalife made up 0.01% of Citigroup's portfolio in Q1 2026, its #1159 holding.
- Citigroup first reported a position in Herbalife in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Herbalife position peaked at $42M in Q2 2020.
- 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.